Foley Attorneys Submitted Two Amicus Briefs to the Federal Circuit Related to ACLU v. Myriad
10 November 2010
Foley attorneys filed two amicus briefs with the Federal Circuit in the AMP et al. v. USPTO et al. (ACLU v. Myriad), a much discussed case relating to gene patents. Foley attorneys submitted one brief on behalf of Rosetta Genomics and George Mason University. Different Foley attorneys also filed a different brief on behalf of Alnylam Pharmaceuticals. Both briefs conclude that isolated DNA composition claims are patent eligible under current law, and should continue to meet the threshold of 35 U.S.C. § 101 when applying scientific facts to the law.
Related News
11 July 2024
Press Releases
Foley Expands Health Care Capabilities with National Team of Corporate and Regulatory Lawyers, Simultaneously Opens Office in Raleigh
Foley announced today that the firm strengthened its Health Care & Life Sciences Sector, adding a group of attorneys and opening a new office in Raleigh, N.C.
26 June 2024
Press Releases
Patrick Daugherty Joins Global Digital Asset and Cryptocurrency Association Steering Committee
Foley & Lardner LLP is pleased to announce that partner Patrick Daugherty is among a select group of distinguished scholars and senior legal
17 June 2024
Press Releases
Foley Expands Texas Presence and Capabilities Across Key Sectors with Addition of Three Attorneys
Foley & Lardner LLP bolstered its Texas presence with the addition of three seasoned attorneys across its Litigation and Business Law Departments. Trey McDonald and James McFall join the firm’s Houston and Dallas offices, respectively, as partners in the Business Litigation & Dispute Resolution Practice and Innovative Technology Sector. Ronald Green, an of counsel with extensive experience in public finance, recently joined the firm’s Finance Practice Group in Houston.